Pharmaceutical Inspection Machines Market to Reach $1.62 Billion by 2031 as Asia-Pacific Growth Accelerates
Updated
Updated · PR Newswire · Jun 11
Pharmaceutical Inspection Machines Market to Reach $1.62 Billion by 2031 as Asia-Pacific Growth Accelerates
2 articles · Updated · PR Newswire · Jun 11
Summary
$1.62 billion is the projected size of the pharmaceutical inspection machines market in 2031, up from $1.14 billion in 2026, implying a 7.2% annual growth rate.
Rising output of generics, vaccines, biologics and specialty drugs is driving demand for faster automated quality checks as manual inspection becomes harder to scale.
Inspection systems held the largest component share in 2025, while conventional machines are expected to command 93.0% of the market in 2026; fully automated machines are forecast to grow faster.
Pharmaceutical companies remained the largest end users in 2025, reflecting heavier spending on AI, machine vision, X-ray and sensor-based systems to meet quality and compliance requirements.
Asia-Pacific is expected to post the fastest regional growth, with India projected to lead major markets at an 8.6% CAGR as manufacturing capacity and regulatory standards expand.